T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Discretionary | 15.13% |
| 3 | Financials | 13.68% |
| 4 | Technology | 12.92% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEB
1251
DELISTED
CEB Inc.
CEB
| $10.3M | ﹤0.01% |
158,690
-900
| -0.6% | -$51.5K |
|
1252
Lincoln Electric
LECO
$15.6B
| $10.3M | ﹤0.01% |
175,326
-4,338
| -2% | -$236K |
|
1253
Essent Group
ESNT
$6.23B
| $10.3M | ﹤0.01% |
493,580
-10,930
| -2% | -$209K |
|
1254
First Solar
FSLR
$24.7B
| $10.2M | ﹤0.01% |
149,255
+17,300
| +13% | +$1.16M |
|
1255
Avis
CAR
$4.84B
| $10.2M | ﹤0.01% |
372,715
-10,000
| -3% | -$273K |
|
1256
United Rentals
URI
$71.9B
| $10.2M | ﹤0.01% |
163,270
-1,590
| -1% | -$88.4K |
|
1257
Walker & Dunlop
WD
$1.48B
| $10.1M | ﹤0.01% |
418,133
+60
| +0% | +$1.42K |
|
|
GRA
1258
DELISTED
W.R. Grace & Co.
GRA
| $10.1M | ﹤0.01% |
142,336
+3,085
| +2% | +$236K |
|
1259
St. Joe Company
JOE
$3.9B
| $10.1M | ﹤0.01% |
589,433
+375,640
| +176% | +$5.93M |
|
|
CPHD
1260
DELISTED
Cepheid Inc
CPHD
| $10.1M | ﹤0.01% |
302,352
-14,989
| -5% | -$471K |
|
1261
Omnicell
OMCL
$1.71B
| $10M | ﹤0.01% |
360,280
+29,570
| +9% | +$812K |
|
1262
Hain Celestial
HAIN
$51.4M
| $9.98M | ﹤0.01% |
243,907
+58,259
| +31% | +$2.19M |
|
|
HZN
1263
DELISTED
Horizon Global Corporation
HZN
| $9.95M | ﹤0.01% |
790,546
+2,330
| +0.3% | +$23.1K |
|
1264
Jacobs Solutions
J
$16.8B
| $9.92M | ﹤0.01% |
275,407
-2
| -0% | -$65 |
|
1265
Inogen
INGN
$154M
| $9.91M | ﹤0.01% |
220,240
+6,800
| +3% | +$242K |
|
1266
REX American Resources
REX
$1.47B
| $9.9M | ﹤0.01% |
1,070,400
+104,100
| +11% | +$898K |
|
1267
Travere Therapeutics
TVTX
$5.74B
| $9.89M | ﹤0.01% |
723,789
+5,700
| +0.8% | +$86.5K |
|
1268
Harmonic Inc
HLIT
$1.5B
| $9.88M | ﹤0.01% |
3,022,277
-776,806
| -20% | -$2.54M |
|
|
PPS
1269
DELISTED
Post Properties
PPS
| $9.8M | ﹤0.01% |
164,042
+1,631
| +1% | +$93.1K |
|
1270
Allot
ALLT
$379M
| $9.79M | ﹤0.01% |
1,872,760
+5,920
| +0.3% | +$29.4K |
|
|
TGNA
1271
DELISTED
TEGNA Inc
TGNA
| $9.73M | ﹤0.01% |
647,927
-950
| -0.1% | -$14.4K |
|
|
LOGM
1272
DELISTED
LogMein, Inc.
LOGM
| $9.67M | ﹤0.01% |
191,550
+5,390
| +3% | +$278K |
|
1273
Comscore
SCOR
$93.6M
| $9.64M | ﹤0.01% |
16,039
-211
| -1% | -$153K |
|
1274
Opko Health
OPK
$993M
| $9.59M | ﹤0.01% |
923,171
-41,350
| -4% | -$378K |
|
1275
Assurant
AIZ
$13.9B
| $9.54M | ﹤0.01% |
123,725
+3,670
| +3% | +$279K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.